I think the direct comparison of TMACS, EDAC and HEART is a bit misleading. They use different testing. T-Macs is predicated on a high sensitivity troponin. EDAC-ADP doesn't say which troponin they used, but excludes patients with ongoing pain.
Highlighting the concepts of knowing how the rule was derived and applied. I.e. how many folks know that the risk factors in HEART include a BMI>30?
Pragmatically, I think HEART, while more subjective in some ways, may be the most well validated and associated with the least risk.
Similar to above - my ED is not yet using high-sensitivity troponin, so I would assume I would not use the T-MACS until this happens. Is the EDACS based on traditional or high-sensitivity troponin? Sorry if you addressed this and I missed it.
TMACS uses hs-TN. I'm not using that since we don't have hs-TN yet. EDACS used conventional TN. Agree with you and also Mike's comment, we need to use the studies exactly as they were validated. We primarily use HEART but it's good to have and know about options.
To join the conversation, you need to subscribe.
Sign up today for full access to all episodes and to join the conversation.
EM:RAP 2020 OctoberFull episode audio for MD edition194:44 min - 204 MB - M4AEM:RAP 2020 October Farsi EditionFarsi159:42 min - 219 MB - MP3EM:RAP 2020 October German EditionDeutsche100:33 min - 138 MB - MP3EM:RAP 2020 October PA EditionPA Edition36:46 min - 50 MB - MP3EM:RAP 2020 October Spanish EditionEspañol75:34 min - 104 MB - MP3EM:RAP 2020 October Aussie EditionAustralian0:49 min - 1 MB - MP3EM:RAP 2020 October Canadian EditionCanadian22:08 min - 30 MB - MP3EM:RAP 2020 October French EditionFrançais21:41 min - 30 MB - MP3EMRAP_2020_10_October_Vol.20 Written Summary446 KB - PDFEM:RAP 2020 October Board Review Answers198 KB - PDFEM:RAP 2020 October Board Review Questions628 KB - PDFEM:RAP 2020 October MP3 Files249 MB - ZIP
Mike J., M.D. - October 28, 2020 1:49 PM
I think the direct comparison of TMACS, EDAC and HEART is a bit misleading. They use different testing. T-Macs is predicated on a high sensitivity troponin. EDAC-ADP doesn't say which troponin they used, but excludes patients with ongoing pain.
Highlighting the concepts of knowing how the rule was derived and applied. I.e. how many folks know that the risk factors in HEART include a BMI>30?
Pragmatically, I think HEART, while more subjective in some ways, may be the most well validated and associated with the least risk.
Mike J.
Mary C. - December 27, 2020 12:36 PM
Similar to above - my ED is not yet using high-sensitivity troponin, so I would assume I would not use the T-MACS until this happens. Is the EDACS based on traditional or high-sensitivity troponin? Sorry if you addressed this and I missed it.
Amal M. - December 29, 2020 5:25 PM
TMACS uses hs-TN. I'm not using that since we don't have hs-TN yet.
EDACS used conventional TN.
Agree with you and also Mike's comment, we need to use the studies exactly as they were validated. We primarily use HEART but it's good to have and know about options.